Department of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address: https://twitter.com/KhushbooSGala.
Department of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address: https://twitter.com/Vbrunaldi.
Gastrointest Endosc Clin N Am. 2024 Oct;34(4):733-742. doi: 10.1016/j.giec.2024.06.007. Epub 2024 Aug 14.
Endoscopic suturing has been described in many applications, including the approximation of tissue defects, anchoring stents, hemostasis, and primary and secondary bariatric interventions. Primary endobariatric procedures use endoscopic suturing for gastric remodeling with the intention of weight loss. Currently, the only commercially available device in the United States is the OverStitch endoscopic suturing system (Apollo Endosurgery). We describe devices of potential that are currently in design and/or trials as devices for weight loss by gastric remodeling, including USGI incisionless operating platform used for the primary obesity surgery endoluminal 2.0 procedure, Endomina used for the Endomina endoscopic sleeve gastroplasty, and EndoZip.
内镜缝合已在许多应用中得到描述，包括组织缺陷的接近、支架固定、止血以及原发性和继发性减重干预。原发性减重内镜手术使用内镜缝合进行胃重塑，目的是减肥。目前，美国唯一可获得的商业设备是 OverStitch 内镜缝合系统（Apollo Endosurgery）。我们描述了目前正在设计和/或试验中的潜在设备，这些设备通过胃重塑来实现减重，包括用于原发性肥胖手术内镜 2.0 程序的 USGI 无切口操作平台、用于 Endomina 内镜袖状胃成形术的 Endomina 以及 EndoZip。
